Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome's composition.
Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...
Illumina, Inc. recently expanded its Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., Chief ...
One of the most detailed maps to date of meningioma, the most common brain tumor in adults, reveals how the tumor’s ...
Over the past decade, the Human Cell Atlas community has accomplished something that will define a generation of biology.
10d
Spatial map of bladder cancer reveals hidden tumor environments, new paths toward precision therapy
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder ...
The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...
Neurological disorders and neuro oncology impose a growing clinical and societal burden, while therapeutic development remains slow, costly, and uncertain.
Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping ...
The integration of artificial intelligence (AI) and multi-omics analysis is rapidly transforming the landscape of drug research and development. In recent ...
Genomics Inc. research and ratings by Barron's. View TXG revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results